One small direct listing is currently scheduled for the week ahead, but movement in the pipeline points to a wave of launches in the short holiday week. We see up to eight companies that could start their roadshows. A few recent filers are primed to launch:...read more
Two multibillion-dollar names joined the pipeline in the final week of the IPO market’s summer doldrums. SoftBank-backed power and data center developer SB Energy (SBE) signals that the dominant theme of the 2026 IPO market, AI infrastructure, will...read more
Eight IPOs raised a combined $29.3 billion in July, joined by three direct listings. New listings raised more than six times July’s 10-year historical average ($4.7B), driven almost entirely by Korea-listed SK hynix (SKHY), which raised $26.5 billion in ...read more
Updated Monday, 7/20. One sizable IPO is currently scheduled for the week ahead, though a few notable names are eligible to launch. Cardiovascular disease biotech Scribe Therapeutics (SCTX) plans to raise $100 million at a $235 million market cap....read more
US IPO Week Ahead: IPO calendar primed for post-Labor Day launches
One small direct listing is currently scheduled for the week ahead, but movement in the pipeline points to a wave of launches in the short holiday week. We see up to eight companies that could start their roadshows. A few recent filers are primed to launch:...read more
US IPO Weekly Recap: SB Energy and Oura headline a pickup in filings
Two multibillion-dollar names joined the pipeline in the final week of the IPO market’s summer doldrums. SoftBank-backed power and data center developer SB Energy (SBE) signals that the dominant theme of the 2026 IPO market, AI infrastructure, will...read more
Renaissance Capital’s July IPO Market Update
Eight IPOs raised a combined $29.3 billion in July, joined by three direct listings. New listings raised more than six times July’s 10-year historical average ($4.7B), driven almost entirely by Korea-listed SK hynix (SKHY), which raised $26.5 billion in ...read more
US IPO Week Ahead: Quiet IPO calendar primed for potential launches
Updated Monday, 7/20. One sizable IPO is currently scheduled for the week ahead, though a few notable names are eligible to launch. Cardiovascular disease biotech Scribe Therapeutics (SCTX) plans to raise $100 million at a $235 million market cap....read more